0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Notable Notes |

Chemical Warfare’s Most Notorious Agent Against the Skin Mustard Gas—Then and Now

Eric Laurent Maranda, BS1; Alexandra Ayache, BS2; Richa Taneja, BS1; Jacqueline Cortizo, BS1; Keyvan Nouri, MD1
[+] Author Affiliations
1University of Miami Miller School of Medicine, Department of Dermatology and Cutaneous Surgery, Miami, Florida
2Lake Erie College of Osteopathic Medicine, Bradenton, Florida
JAMA Dermatol. 2016;152(8):933. doi:10.1001/jamadermatol.2016.0179.
Text Size: A A A
Published online

Extract

In July of 1917, the allied forces rallied against the German Empire, in a battle fought in the trenches of the Ypres salient, a highly sought-after territory of Belgium. In these critical battles of World War I, the use of chemical warfare took hold as nations began to effectively demoralize, deface, and kill entrenched defenders. Gas masks, initially developed to counteract the effects of these killers, were rendered useless against the most effective and widely used gas of the World War I, mustard gas.1 Although this development was an ineffective killing agent, its notorious ability to disable opponents prompted its rampant popularity. Mustard gas was unique in its capacity to target the organ at the frontline of man’s protection: the skin.

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

110 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();